A recent study by Yin et al., demonstrated this potential in an intracranial xenograft model of glioblastoma, in which PPP demonstrated ability to cross the blood–brain-barrier and cause tumor regression as well as downregulation of p-AKT [52]. This evidence concerns the gene AKT1 and glioblastoma.